{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:59:14Z","timestamp":1792425554970,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51959-6","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T11:02:14Z","timestamp":1725015734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-5362","authenticated-orcid":false,"given":"Asolina","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0649-5089","authenticated-orcid":false,"given":"Louise C.","family":"Rowntree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Thuesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1847-754X","authenticated-orcid":false,"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5904-1905","authenticated-orcid":false,"given":"Dene R.","family":"Littler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1499-6664","authenticated-orcid":false,"given":"Shabana","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-7693","authenticated-orcid":false,"given":"Thi H. O.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Jappe Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2901-7335","authenticated-orcid":false,"given":"Gry","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schantz Klausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7415-3283","authenticated-orcid":false,"given":"Jens","family":"Kringelum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzou","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-5127","authenticated-orcid":false,"given":"Nathan P.","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-3356","authenticated-orcid":false,"given":"Pouya","family":"Faridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-7522","authenticated-orcid":false,"given":"Jamie","family":"Rossjohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3870-0796","authenticated-orcid":false,"given":"Patricia T.","family":"Illing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-7685","authenticated-orcid":false,"given":"Katherine E.","family":"Scull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri","family":"Ramarathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-2102","authenticated-orcid":false,"given":"Nicole A.","family":"Mifsud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6141-335X","authenticated-orcid":false,"given":"Katherine","family":"Kedzierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Bundg\u00e5rd","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0532-8331","authenticated-orcid":false,"given":"Anthony W.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"51959_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","volume":"592","author":"JA Plante","year":"2021","unstructured":"Plante, J. A. et al. Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592, 116\u2013121 (2021).","journal-title":"Nature"},{"key":"51959_CR2","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1016\/S2666-5247(21)00068-9","volume":"2","author":"S Jangra","year":"2021","unstructured":"Jangra, S. et al. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe 2, e283\u2013e284 (2021).","journal-title":"Lancet Microbe"},{"key":"51959_CR3","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.abg8985","volume":"372","author":"JS Low","year":"2021","unstructured":"Low, J. S. et al. Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science 372, 1336\u20131341 (2021).","journal-title":"Science"},{"key":"51959_CR4","doi-asserted-by":"publisher","first-page":"eabg5669","DOI":"10.1126\/sciimmunol.abg5669","volume":"6","author":"V Mallajosyula","year":"2021","unstructured":"Mallajosyula, V. et al. CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients. Sci. Immunol. 6, eabg5669 (2021).","journal-title":"Sci. Immunol."},{"key":"51959_CR5","doi-asserted-by":"crossref","unstructured":"Augusto, D. G. et al. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature 620, 128\u2013136 (2023).","DOI":"10.1038\/s41586-023-06331-x"},{"key":"51959_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","volume":"25","author":"K Yin","year":"2024","unstructured":"Yin, K. et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol. 25, 218\u2013225 (2024).","journal-title":"Nat. Immunol."},{"key":"51959_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41590-022-01175-5","volume":"23","author":"KM Wragg","year":"2022","unstructured":"Wragg, K. M. et al. Establishment and recall of SARS-CoV-2 spike epitope-specific CD4(+) T cell memory. Nat. Immunol. 23, 768\u2013780 (2022).","journal-title":"Nat. Immunol."},{"key":"51959_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.803031","volume":"12","author":"LN Yan","year":"2021","unstructured":"Yan, L. N. et al. Neutralizing antibodies and cellular immune responses against SARS-CoV-2 sustained one and a half years after natural infection. Front Microbiol 12, 803031 (2021).","journal-title":"Front Microbiol"},{"key":"51959_CR9","doi-asserted-by":"publisher","first-page":"eabf7517","DOI":"10.1126\/scitranslmed.abf7517","volume":"13","author":"T Bilich","year":"2021","unstructured":"Bilich, T. et al. T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Sci. Transl. Med 13, eabf7517 (2021).","journal-title":"Sci. Transl. Med"},{"key":"51959_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101017","volume":"4","author":"THO Nguyen","year":"2023","unstructured":"Nguyen, T. H. O. et al. Robust SARS-CoV-2 T cell responses with common TCRalphabeta motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells. Cell Rep. Med 4, 101017 (2023).","journal-title":"Cell Rep. Med"},{"key":"51959_CR11","doi-asserted-by":"crossref","unstructured":"Geers, D. et al. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. Sci. Immunol. 6, eabj1750 (2021).","DOI":"10.1126\/sciimmunol.abj1750"},{"key":"51959_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1135815","volume":"14","author":"B Carter","year":"2023","unstructured":"Carter, B. et al. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta. Front. Immunol. 14, 1135815 (2023).","journal-title":"Front. Immunol."},{"key":"51959_CR13","doi-asserted-by":"publisher","first-page":"1166546","DOI":"10.3389\/fimmu.2023.1166546","volume":"14","author":"G Persson","year":"2023","unstructured":"Persson, G. et al. DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 mice. Front. Immunol. 14, 1166546 (2023).","journal-title":"Front. Immunol."},{"key":"51959_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38751-8","volume":"14","author":"W Tai","year":"2023","unstructured":"Tai, W. et al. An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants. Nat. Commun. 14, 2962 (2023).","journal-title":"Nat. Commun."},{"key":"51959_CR15","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.cell.2023.04.007","volume":"186","author":"CM Arieta","year":"2023","unstructured":"Arieta, C. M. et al. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection. Cell 186, 2392\u20132409.e2321 (2023).","journal-title":"Cell"},{"key":"51959_CR16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","volume":"14","author":"AW Purcell","year":"2019","unstructured":"Purcell, A. W., Ramarathinam, S. H. & Ternette, N. Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics. Nat. Protoc. 14, 1687\u20131707 (2019).","journal-title":"Nat. Protoc."},{"key":"51959_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00251-023-01295-8","volume":"75","author":"M Brand","year":"2023","unstructured":"Brand, M. & Ke\u015fmir, C. Evolution of SARS-CoV-2-specific CD4(+) T cell epitopes. Immunogenetics 75, 283\u2013293 (2023).","journal-title":"Immunogenetics"},{"key":"51959_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.vaccine.2023.12.024","volume":"42","author":"T Ratishvili","year":"2024","unstructured":"Ratishvili, T. et al. A multifaceted approach for identification, validation, and immunogenicity of naturally processed and in silico-predicted highly conserved SARS-CoV-2 peptides. Vaccine 42, 162\u2013174 (2024).","journal-title":"Vaccine"},{"key":"51959_CR19","doi-asserted-by":"publisher","first-page":"101725","DOI":"10.1016\/j.smim.2023.101725","volume":"66","author":"SM Schroeder","year":"2023","unstructured":"Schroeder, S. M., Nelde, A. & Walz, J. S. Viral T-cell epitopes - Identification, characterization and clinical application. Semin. Immunol. 66, 101725 (2023).","journal-title":"Semin. Immunol."},{"key":"51959_CR20","doi-asserted-by":"publisher","first-page":"876380","DOI":"10.3389\/fbinf.2022.876380","volume":"2","author":"A Tarke","year":"2022","unstructured":"Tarke, A., Grifoni, A. & Sette, A. Bioinformatic and experimental analysis of t cell immune reactivity to SARS-CoV-2 and its variants. Front Bioinform. 2, 876380 (2022).","journal-title":"Front Bioinform."},{"key":"51959_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77466-4","volume":"10","author":"M Prachar","year":"2020","unstructured":"Prachar, M. et al. Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools. Sci. Rep. 10, 20465 (2020).","journal-title":"Sci. Rep."},{"key":"51959_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109179","volume":"35","author":"R Parker","year":"2021","unstructured":"Parker, R. et al. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. Cell Rep. 35, 109179 (2021).","journal-title":"Cell Rep."},{"key":"51959_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108454","volume":"33","author":"MD Knierman","year":"2020","unstructured":"Knierman, M. D. et al. The human leukocyte antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein. Cell Rep. 33, 108454 (2020).","journal-title":"Cell Rep."},{"key":"51959_CR24","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","volume":"184","author":"S Weingarten-Gabbay","year":"2021","unstructured":"Weingarten-Gabbay, S. et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell 184, 3962\u20133980.e3917 (2021).","journal-title":"Cell"},{"key":"51959_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113596","volume":"43","author":"S Weingarten-Gabbay","year":"2024","unstructured":"Weingarten-Gabbay, S. et al. The HLA-II immunopeptidome of SARS-CoV-2. Cell Rep. 43, 113596 (2024).","journal-title":"Cell Rep."},{"key":"51959_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109305","volume":"35","author":"A Nagler","year":"2021","unstructured":"Nagler, A. et al. Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics. Cell Rep. 35, 109305 (2021).","journal-title":"Cell Rep."},{"key":"51959_CR27","doi-asserted-by":"publisher","first-page":"e2111815118","DOI":"10.1073\/pnas.2111815118","volume":"118","author":"K Pan","year":"2021","unstructured":"Pan, K. et al. Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs. Proc. Natl Acad. Sci. USA 118, e2111815118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"51959_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1269335","volume":"14","author":"S Yin","year":"2023","unstructured":"Yin, S. et al. Integrated immunopeptidomic and proteomic analysis of COVID-19 lung biopsies. Front. Immunol. 14, 1269335 (2023).","journal-title":"Front. Immunol."},{"key":"51959_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1399-0039.2006.00769.x","volume":"69","author":"AK Lancaster","year":"2007","unstructured":"Lancaster, A. K., Single, R. M., Solberg, O. D., Nelson, M. P. & Thomson, G. PyPop update-a software pipeline for large-scale multilocus population genomics. Tissue Antigens 69, 192\u2013197 (2007).","journal-title":"Tissue Antigens"},{"key":"51959_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","volume":"583","author":"D Bojkova","year":"2020","unstructured":"Bojkova, D. et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583, 469\u2013472 (2020).","journal-title":"Nature"},{"key":"51959_CR31","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1002\/cpz1.92","volume":"1","author":"K Pandey","year":"2021","unstructured":"Pandey, K., Ramarathinam, S. H. & Purcell, A. W. Isolation of HLA bound peptides by immunoaffinity capture and identification by mass Spectrometry. Curr. Protoc. 1, e92 (2021).","journal-title":"Curr. Protoc."},{"key":"51959_CR32","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1084\/jem.184.6.2279","volume":"184","author":"SW Reid","year":"1996","unstructured":"Reid, S. W. et al. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J. Exp. Med 184, 2279\u20132286 (1996).","journal-title":"J. Exp. Med"},{"key":"51959_CR33","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.4049\/jimmunol.1800914","volume":"201","author":"D Gfeller","year":"2018","unstructured":"Gfeller, D. et al. The length distribution and multiple specificity of naturally presented HLA-I ligands. J. Immunol. 201, 3705\u20133716 (2018).","journal-title":"J. Immunol."},{"key":"51959_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","volume":"38","author":"S Sarkizova","year":"2020","unstructured":"Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199\u2013209 (2020).","journal-title":"Nat. Biotechnol."},{"key":"51959_CR35","doi-asserted-by":"publisher","first-page":"e2000160","DOI":"10.1002\/pmic.202000160","volume":"21","author":"SH Ramarathinam","year":"2021","unstructured":"Ramarathinam, S. H., Ho, B. K., Dudek, N. L. & Purcell, A. W. HLA class II immunopeptidomics reveals that co-inherited HLA-allotypes within an extended haplotype can improve proteome coverage for immunosurveillance. Proteomics 21, e2000160 (2021).","journal-title":"Proteomics"},{"key":"51959_CR36","doi-asserted-by":"crossref","unstructured":"Mei, S. Immunopeptidomic analysis reveals that deamidated HLA-bound peptides arise predominantly from deglycosylated precursors. Mol. Cell Proteomics 19, 1236\u20131247 (2020).","DOI":"10.1074\/mcp.RA119.001846"},{"key":"51959_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100563","volume":"22","author":"KM Phulphagar","year":"2023","unstructured":"Phulphagar, K. M. et al. Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry. Mol. Cell Proteom. 22, 100563 (2023).","journal-title":"Mol. Cell Proteom."},{"key":"51959_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44460-z","volume":"15","author":"H Liao","year":"2024","unstructured":"Liao, H. et al. MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer. Nat. Commun. 15, 661 (2024).","journal-title":"Nat. Commun."},{"key":"51959_CR39","unstructured":"Supekar, N. T. et al. Variable post-translational modifications of SARS-CoV-2 nucleocapsid protein. Glycobiology 31, 1080\u20131092 (2021)."},{"key":"51959_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202100036","volume":"21","author":"C Li","year":"2021","unstructured":"Li, C. et al. Resourcing, annotating, and analysing synthetic peptides of SARS-CoV-2 for immunopeptidomics and other immunological studies. Proteomics 21, e2100036 (2021).","journal-title":"Proteomics"},{"key":"51959_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"51959_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40758-0","volume":"14","author":"JS Heitmann","year":"2023","unstructured":"Heitmann, J. S. et al. Phase I\/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency. Nat. Commun. 14, 5032 (2023).","journal-title":"Nat. Commun."},{"key":"51959_CR43","doi-asserted-by":"publisher","first-page":"e000468","DOI":"10.1136\/bmjmed-2022-000468","volume":"2","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. T cell immune memory after covid-19 and vaccination. BMJ Med. 2, e000468 (2023).","journal-title":"BMJ Med."},{"key":"51959_CR44","doi-asserted-by":"crossref","unstructured":"Ogando, N. S. et al. The enzymatic activity of the nsp14 Exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J. Virol. 94, e01246\u201320 (2020).","DOI":"10.1128\/JVI.01246-20"},{"key":"51959_CR45","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1107\/S0907444906029799","volume":"62","author":"AR Aricescu","year":"2006","unstructured":"Aricescu, A. R., Lu, W. & Jones, E. Y. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D. Biol. Crystallogr 62, 1243\u20131250 (2006).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"51959_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-017-0060-7","volume":"19","author":"XT Fang","year":"2017","unstructured":"Fang, X. T., Sehlin, D., Lannfelt, L., Syvanen, S. & Hultqvist, G. Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells. Biol. Proced. Online 19, 11 (2017).","journal-title":"Biol. Proced. Online"},{"key":"51959_CR47","doi-asserted-by":"publisher","first-page":"101258","DOI":"10.1016\/j.isci.2020.101258","volume":"23","author":"DR Littler","year":"2020","unstructured":"Littler, D. R., Gully, B. S., Colson, R. N. & Rossjohn, J. Crystal structure of the SARS-CoV-2 non-structural Protein 9, Nsp9. iScience 23, 101258 (2020).","journal-title":"iScience"},{"key":"51959_CR48","doi-asserted-by":"publisher","first-page":"eabe9403","DOI":"10.1126\/science.abe9403","volume":"370","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science 370, eabe9403 (2020).","journal-title":"Science"},{"key":"51959_CR49","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468 (2020).","journal-title":"Nature"},{"key":"51959_CR50","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/pmic.201100463","volume":"12","author":"C Escher","year":"2012","unstructured":"Escher, C. et al. Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics 12, 1111\u20131121 (2012).","journal-title":"Proteomics"},{"key":"51959_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","volume":"1","author":"S Elbe","year":"2017","unstructured":"Elbe, S. & Buckland-Merrett, G. Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health. Glob. Chall. 1, 33\u201346 (2017).","journal-title":"Glob. Chall."},{"key":"51959_CR52","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.4049\/jimmunol.2000249","volume":"205","author":"LC Rowntree","year":"2020","unstructured":"Rowntree, L. C. et al. A Shared TCR Bias toward an Immunogenic EBV Epitope Dominates in HLA-B*07:02-Expressing Individuals. J. Immunol. 205, 1524\u20131534 (2020).","journal-title":"J. Immunol."},{"key":"51959_CR53","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.csbj.2023.02.033","volume":"21","author":"PR Munday","year":"2023","unstructured":"Munday, P. R. et al. Immunolyser: A web-based computational pipeline for analysing and mining immunopeptidomic data. Comput Struct. Biotechnol. J. 21, 1678\u20131687 (2023).","journal-title":"Comput Struct. Biotechnol. J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51959-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51959-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51959-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:03:12Z","timestamp":1725019392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51959-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51959"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51959-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3564516\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"5 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NT, EJL, GP, MSK, JVK, and ABS are employed by Evaxion Biotech A\/S which holds IP for identifying neoepitopes and personalized immunotherapy. AWP is on the scientific advisory board of Evaxion Biotech A\/S. AWP is on the advisory board of Bioinformatics Solutions (Canada), and Grey Wolf Therapeutics (UK) and is a co-founder of Resseptor Therapeutics (Australia). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human blood samples were collected between 12-223 days post-SARS-CoV-2 infection in heparinised tubes. Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient centrifugation (Ficoll-Paque, Cytiva) and cryopreserved in fetal calf serum with 10% DMSO (Cat# D2650, Sigma-Aldrich). All human experimental work was conducted according to the Declaration of Helsinki principles and the Australian NHMRC Code of Practice. All blood donors provided written informed consent. Ethics approval was granted from the Human Research Ethics Committee of Melbourne Health (HREC\/66341\/MH-2020) and The University of Melbourne (13344 and 20782).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7547"}}